17 research outputs found
High-dose methotrexate ameliorates collagen-induced arthritis but does not inhibit the release of proinflammatory cytokines by peritoneal macrophages in mice
Vitamin D serum concentration is not related to the activity of spondyloarthritis : preliminary study
Objective: Vitamin D plays an important role in mineral turnover and bone remodeling and there
are increasing data about its immunomodulatory potential in different rheumatologic disorders.
Deficiency of vitamin D is frequent in patients with spondyloarthritis (SpA) and some data suggest
its association with increased disease activity and structural damage. However, its exact role in the
pathogenesis of SpA and its association with disease activity are still a matter of debate.
Material and methods: A cross-sectional study of patients diagnosed with axial spondyloarthritis
(axSpA) and peripheral spondyloarthritis (perSpA) according to Assessment of Spondyloarthritis
International Society classification criteria was performed. The correlation between concentration
of 25-hydroxyvitamin D - 25(OH)D - and disease activity scores (Bath Ankylosing Spondylitis
Disease Activity Index - BASDAI, Ankylosing Spondylitis Disease Activity Score - ASDAS), inflammatory
markers (C-reactive protein - CRP, erythrocyte sedimentation rate - ESR) and clinical symptoms
(arthritis, enthesitis, dactylitis) was performed.
Results: We included 40 patients with axSpA and 23 patients with perSpA. The mean concentration
of 25(OH)D was 24.9 ng/ml (SD 12.49). Forty-seven (74.6%) patients had 25(OH)D below the
recommended threshold (< 30 ng/ml). We found no statistically significant negative correlation between
the level of 25(OH)D and disease activity of axSpA and perSpA in terms of clinical symptoms
(arthritis, enthesitis, dactylitis), inflammatory markers (ESR, CRP) and disease activity scores
(BASDAI, ASDAS). These results did not change after adjustment for supplementation of vitamin D
and seasonal variation.
Conclusions: Our data show no correlation between the concentration of 25(OH)D in the serum
and disease activity in two subgroups of SpA. However, this does not exclude the potential role of
vitamin D in pathogenesis of SpA. Further studies are required to evaluate the optimal range of
25(OH)D serum concentration in axSpA and perSpA patients with its possible immunomodulatory
potential and influence on disease activity
Yttrium-90 distribution following radiosynoviorthesis of the knee joint in rheumatoid arthritis patients : a SPECT/CT study
Objective
To examine yttrium-90 distribution 1 and 72 h following its injection into a knee joint in patients with rheumatoid arthritis (RA).
Methods
In 14 RA patients we injected yttrium-90 into the affected knee joint using lateral approach. To assess the radioisotope distribution in the joint, the superimposed sequential SPECT and CT imaging was performed 1 and 72 h after the injection. We analyzed the percentage of radioisotope distribution in three predefined compartments of the knee joint (lower, upper medial, upper lateral).
Results
After 1 and 72 h, the mean percentage distributions were, respectively, 7.14 and 23.07 % in lower; 21.42 and 15.38 % in upper medial, and 71.42 and 61.53 % in upper lateral compartment. The percentage of isotope deposition did not change significantly with time in any of the compartments (all p > 0.26). The deposition of isotope, both at 1 and 72 h, was significantly greater in upper lateral compartment, where the injection was performed, than in all other compartments (all p < 0.05).
Conclusions
Using the SPECT/CT hybrid method, we proved that the majority of isotope is located at the compartment adjacent to the injection. Two injections targeting different compartments might improve the clinical efficacy of the procedure
Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration
Objectives. To estimate endothelial dysfunction in patients with rheumatoid arthritis (RA) of short duration in relation to disease activity based on the assessment of 28 joints (DAS28). Methods. We studied 29 patients (22 women, mean age 41 (SD, 9) years) with RA of short duration and 29 healthy controls. The RA subjects were divided into those with low (DAS28: 2.6–5.1, n=18) or high (DAS28>5.1, n=11) disease activity. Exclusion criteria included clinically overt atherosclerosis and other coexistent diseases. Biochemical markers of inflammatory activation and endothelial dysfunction were measured. Results. There were no significant intergroup differences in the majority of classical cardiovascular risk factors. High-sensitivity C-reactive protein, tumor necrosis factor-α, and interleukin-6 were increased in RA subjects. Compared to the controls, levels of soluble vascular cell adhesion molecule-1, von Willebrand factor, and pentraxin-3 were significantly elevated in RA subjects with low disease activity, exhibiting no further significant rises in those with high disease activity. Asymmetric dimethyl-L-arginine, soluble E-selectin, monocyte chemotactic protein-1, and osteoprotegerin were increased only in RA patients with high disease activity. Conclusions. Our findings might suggest a dissociation of pathways governing generalized and joint-specific inflammatory reactions from those involved in endothelial activation and inflammation within the vascular wall
Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
Results from Polish Spondyloarthritis Initiative registry (PolSPI) : methodology and data from : the first year of observation
Objectives: Report on one-year results from the Polish Spondyloarthritis Initiative registry (PolSPI),
containing the cross-sectional analysis of clinical and imaging data as well as database methodology.
Material and methods: The PolSPI registry includes patients with axial (axSpA) and peripheral (per-
SpA) spondyloarthritis according to ASAS classification criteria, and/or patients with ankylosing
spondylitis according to modified New York criteria, psoriatic arthritis according to CASPAR criteria,
arthropathy in inflammatory bowel disease, reactive arthritis, juvenile spondyloarthritis or undifferentiated
spondyloarthritis. Epidemiologic data and history of signs, symptoms and treatment of
spondyloarthritis are collected and assessment of disease activity is performed. Radiographic images
of sacroiliac joint, cervical and lumbar spine, and results of bone densitometry are collected. Every
6 months blood samples for inflammatory markers, and for long-term storage are taken.
Results: During a one-year period from September 2015 to August 2016, 63 patients were registered
on an electronic database; 44 (69.8%) of patients were classified as axial spondyloarthritis (axSpA) and
19 (30.2%) as peripheral spondyloarthritis (perSpA) according to ASAS criteria. Statistically significant
differences between axSpA and perSpA were discovered in the percentage of HLA-B27 antigen occurrence
(92.6% and 50%, respectively), BASDAI (2.8% and 4.1%, respectively), DAS 28 (2.66% and 4.03%,
respectively), percentage of peripheral arthritis (20% and 88.8%, respectively), enthesitis (26.7% and
70.6%, respectively), dactylitis (6.7% and 88.9%, respectively), as well as extra-articular symptoms:
acute anterior uveitis (26.7% and 5.6% , respectively) and psoriasis (6.9% and 55.6%, respectively).
Patients with axSpA had significantly higher mean grade of sacroiliac involvement according to New
York criteria, higher mSASSS score, and lower T-score in femoral neck in bone densitometry.
Conclusions: At the early stage of the disease patients with axSpA compared to those with perSpA,
have more advanced structural damage of sacroiliac joints and spine, and lower bone mineral density in the femoral neck. In the upcoming years the PolSPI registry will prospectively follow-up
patients with SpA, recording response to treatment and carrying out research on interaction of
inflammation and bone remodelling